ML18037B126: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
Line 16: Line 16:


=Text=
=Text=
{{#Wiki_filter:February 6, 2018 UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION In the Matter of )  
{{#Wiki_filter:February 6, 2018 UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION In the Matter of )  
  ) NORTHWEST MEDICAL ISOTOPES, LLC ) Docket No. 50-609-CP  )  
  ) NORTHWEST MEDICAL ISOTOPES, LLC ) Docket No. 50-609-CP  )  
(Medical Radioisotope Production Facility) )  
(Medical Radioisotope Production Facility) )  
  )
  )
NRC STAFF REVISED EXHIBIT LIST The U.S. Nuclear Regulatory Commission (NRC) staff (Staff) hereby files its revised exhibit list for the mandatory hearing on the construction permit application of Northwest Medical Isotopes, LLC (NWMI) to reflect the inclusion of Exhibit NRC-014, "NRC Staff Responses to Commission Post-Hearing Questions," which was filed today. As noted in that exhibit, NWMI does not object to the admission of NRC-014. Respectfully submitted, /Signed (electronically) by/      Mitzi A. Young Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel Mail Stop O14-A44 Washington, DC  20555 Telephone: (301) 287-9178 E-mail:  Mitzi.Young@nrc.gov Executed in accord with 10 CFR 2.304(d) Jeremy L. Wachutka      Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel Mail Stop O14-A44  Washington, DC  20555 Telephone: (301) 287-9188 E-mail : Jeremy.Wachutka@nrc.gov Dated at Rockville, Maryland this 6th day of February, 2018 Staff Exhibits for NWMI Mandatory Hearing (Revised February 6, 2018) Exhibit Number Sponsoring Witness(es) Document Description/Title NRC-001 MaryJane Ross-Lee and Joseph Donoghue SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility (Nov. 16, 2017) (ADAMS Accession No. ML17313A037). NRC-002 MaryJane Ross-Lee Draft Construction Permit for Northwest Medical Isotopes, LLC (Nov. 17, 2017) (ADAMS Accession No. ML17313A100) (revised Jan. 16, 2018). NRC-003 Joseph Donoghue Draft Summary Record of Decision, Construction Permit Application for the Northwest Medical Isotopes, LLC Radioisotope Production Facility (Nov.
NRC STAFF REVISED EXHIBIT LIST The U.S. Nuclear Regulatory Commission (NRC) staff (Staff) hereby files its revised exhibit list for the mandatory hearing on the construction permit application of Northwest Medical Isotopes, LLC (NWMI) to reflect the inclusion of Exhibit NRC-014, "NRC Staff Responses to Commission Post-Hearing Questions," which was filed today. As noted in that exhibit, NWMI does not object to the admission of NRC-014.
Respectfully submitted,  
/Signed (electronically) by/      Mitzi A. Young Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel Mail Stop O14-A44 Washington, DC  20555 Telephone: (301) 287-9178  
 
E-mail:  Mitzi.Young@nrc.gov Executed in accord with 10 CFR 2.304(d)
Jeremy L. Wachutka      Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel  
 
Mail Stop O14-A44  Washington, DC  20555 Telephone: (301) 287-9188  
 
E-mail : Jeremy.Wachutka@nrc.gov Dated at Rockville, Maryland this 6th day of February, 2018
 
Staff Exhibits for NWMI Mandatory Hearing (Revised February 6, 2018)
Exhibit Number Sponsoring Witness(es)
Document Description/Title NRC-001 MaryJane Ross-Lee and Joseph Donoghue SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility (Nov. 16, 2017) (ADAMS Accession No. ML17313A037). NRC-002 MaryJane Ross-Lee Draft Construc tion Permit for Northwest Medical Isotopes, LLC (Nov. 17, 2017) (ADAMS Accession No. ML17313A100) (revised Jan. 16, 2018). NRC-003 Joseph Donoghue Draft Summary Record of Decision, Construction Permit Application for the Northwest Medical Isotopes, LLC Radioisotope Production Facility (Nov.  
 
17, 2017) (ADAMS Accession No. ML17313A338)  
17, 2017) (ADAMS Accession No. ML17313A338)  
(revised Jan. 16, 2018). NRC-004 MaryJane Ross-Lee and Joseph Donoghue NRC Staff Revised Responses to Commission Pre-Hearing Questions (Jan. 16, 2018) (ADAMS Accession No. ML18016A554). NRC-005 MaryJane Ross-Lee and Joseph Donoghue NON-PUBLIC - NRC Staff Responses to Non-Public Pre-Hearing Questions and Non-Public Response to Question 36 (Jan. 2, 2018) (ADAMS Accession No. ML18002A546). NRC-006A MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - Cover Letter and General and Financial Information (Feb. 5, 2015) (ADAMS Accession Nos. ML15086A262 and ML15086A263 (in part)). NRC-006B MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - Preliminary Safety Analysis Report (PSAR), NWMI-2013-021, Rev. 3, Chapters 1 through 2 (Sep. 2017) (ADAMS Accession Nos.
(revised Jan. 16, 2018). NRC-004 MaryJane Ross-Lee and Joseph Donoghue NRC Staff Revised Responses to Commission Pre-Hearing Questions (Jan. 16, 2018) (ADAMS Accession No. ML18016A554). NRC-005 MaryJane Ross-Lee and Joseph Donoghue NON-PUBLIC - NRC Staff Responses to Non-Public Pre-Hearing Questions and Non-Public Response to Question 36 (Jan. 2, 2018)
ML17257A022 and ML17257A023). NRC-006C MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 3 (Sep. 2017) (ADAMS Accession No.
(ADAMS Accession No. ML18002A546). NRC-006A MaryJane Ross-Lee Northwest M edical Isotopes, LLC, Construction Permit Application - Cover Letter and General and Financial Information (Feb. 5, 2015) (ADAMS Accession Nos. ML15086A262 and ML15086A263 (in  
ML17257A024). NRC-006D MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 4 (Sep. 2017) (ADAMS Accession No. ML17257A025). NRC-006E MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 5 through 10 (Sep. 2017) (ADAMS Accession Nos. ML17257A026, ML17257A027, ML17257A028, ML17257A029, ML17257A030, and ML17257A031, respectively). NRC-006F MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 11 through 12 (Sep. 2017) (ADAMS Accession Nos. ML17257A032 and ML17257A033). NRC-006G MaryJane Ross-Lee Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 13 through 18 (Sep. 2017) (ADAMS Accession Nos. ML17257A034, ML17257A035, ML17257A036, ML17257A037, ML17257A038, and ML17257A040, respectively). NRC-006H Joseph Donoghue Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev.
 
OA, Chapter 19, Beginning through 19-130 (Jun.
part)). NRC-006B MaryJane Ross-Lee Northwest M edical Isotopes, LLC, Construction Permit Application - Preliminary Safety Analysis Report (PSAR), NWMI-2013-021, Rev. 3, Chapters 1 through 2 (Sep. 2017) (ADAMS Accession Nos.
ML17257A022 and ML17257A023). NRC-006C MaryJane Ross-Lee Northwest M edical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3,  
 
Chapter 3 (Sep. 2017) (ADAMS Accession No.
ML17257A024). NRC-006D MaryJane Ross-Lee Northwest M edical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 4 (Sep. 2017) (ADAMS Accession No. ML17257A025). NRC-006E MaryJane Ross-Lee Northwest M edical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3,  
 
Chapters 5 through 10 (Sep. 2017) (ADAMS Accession Nos. ML17257A026, ML17257A027, ML17257A028, ML17257A029, ML17257A030, and ML17257A031, respectively).
NRC-006F MaryJane Ross-Lee Northwest M edical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 11 through 12 (Sep. 2017) (ADAMS Accession Nos. ML17257A032 and ML17257A033). NRC-006G MaryJane Ross-Lee Northwest M edical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 13 through 18 (Sep. 2017) (ADAMS Accession Nos. ML17257A034, ML17257A035, ML17257A036, ML17257A037, ML17257A038, and ML17257A040, respectively). NRC-006H Joseph Donoghue Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev.
OA, Chapter 19, Beginning through 19-130 (Jun.  
 
2015) (ADAMS Accession Nos. ML15210A123 and ML15210A131). NRC-006I Joseph Donoghue Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. OA, Chapter 19, 19-131 through End (Jun. 2015)  
2015) (ADAMS Accession Nos. ML15210A123 and ML15210A131). NRC-006I Joseph Donoghue Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. OA, Chapter 19, 19-131 through End (Jun. 2015)  
(ADAMS Accession Nos. ML15210A128 and ML15210A129). NRC-007A MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - General and Financial Information (Feb. 5, 2015) (ADAMS Accession No. ML15086A272 (in part)). NRC-007B MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 1 through 2 (Sep. 2017)  
(ADAMS Accession Nos. ML15210A128 and ML15210A129). NRC-007A MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - General and Financial Information (Feb. 5, 2015) (ADAMS Accession No. ML15086A272 (in part)). NRC-007B MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 1 through 2 (Sep. 2017)  
(ADAMS Accession Nos. ML17257A044 and ML17257A045). NRC-007C MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 3 (Sep. 2017) (ADAMS Accession No. ML17257A046). NRC-007D MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 4 (Sep. 2017) (ADAMS Accession No. ML17257A047). NRC-007E MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 5 through 8 (Sep. 2017)  
(ADAMS Accession Nos. ML17257A044 and ML17257A045). NRC-007C MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-
(ADAMS Accession Nos. ML17257A048, ML17257A049, ML17257A050, and ML17257A051, respectively). NRC-007F MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 9 through 11 (Sep.
 
2017) (ADAMS Accession Nos. ML17257A052, ML17257A053, and ML17257A054, respectively). NRC-007G MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 12 through 13 (Sep.
2013-021, Rev. 3, Chapter 3 (Sep. 2017) (ADAMS Accession No. ML17257A046). NRC-007D MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 4 (Sep. 2017) (ADAMS Accession No. ML17257A047). NRC-007E MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-
2017) (ADAMS Accession Nos. ML17257A055 and ML17257A056). NRC-007H MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 14 through 18 (Sep. 2017) (ADAMS Accession Nos. ML17257A057, ML17257A058, ML17257A059, ML17257A060, and ML17257A061, respectively). NRC-007I Joseph Donoghue NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 0A, Chapter 19, Beginning through 19-108 (Jun. 2015) (ADAMS Accession Nos. ML15211A223 and ML15211A224). NRC-007J Joseph Donoghue NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 0A, Chapter 19, 19-109 through End (Jun. 2015) (ADAMS Accession Nos.
 
ML15211A225 and ML15211A226). NRC-008 MaryJane Ross-Lee Safety Evaluation Report Related to the Northwest Medical Isotopes, LLC Construction Permit Application for a Production Facility (Nov. 2017) (ADAMS Accession No. ML18016A021) (as revised Jan. 2018). NRC-009 Joseph Donoghue NUREG-2209, Final Environmental Impact Statement for the Construction Permit for Northwest Medical Isotopes Radioisotope Production Facility (May 2017)  
2013-021, Rev. 3, Chapters 5 through 8 (Sep. 2017)  
(ADAMS Accession No. ML17130A862). NRC-010 MaryJane Ross-Lee and Joseph Donoghue Staff Presentation Slides - Overview (Jan. 16, 2018). (ADAMS Accession No. ML18016BA074) NRC-011 MaryJane Ross-Lee Staff Presentation Slides - Safety Panel 1 (Jan. 16, 2018). NRC-012 MaryJane Ross-Lee Staff Presentation Slides - Safety Panel 2 (Jan. 16, 2018). NRC-013 Joseph Donoghue Staff Presentation Slides - Environmental Panel (Jan. 16, 2018). NRC-014 MaryJane Ross-Lee, Joseph Donoghue and Brian Smith NRC Staff Responses to Commission Post-Hearing Questions (Feb. 6, 2018)
(ADAMS Accession Nos. ML17257A048, ML17257A049, ML17257A050, and ML17257A051, respectively). NRC-007F MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-
UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION In the Matter of )  
 
2013-021, Rev. 3, Chapters 9 through 11 (Sep.
2017) (ADAMS Accession Nos. ML17257A052, ML17257A053, and ML17257A054, respectively).
NRC-007G MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-
 
2013-021, Rev. 3, Chapters 12 through 13 (Sep.
2017) (ADAMS Accession Nos. ML17257A055 and ML17257A056).
NRC-007H MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 14 through 18 (Sep. 2017) (ADAMS Accession Nos. ML17257A057, ML17257A058, ML17257A059, ML17257A060, and ML17257A061, respectively). NRC-007I Joseph Donoghue NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-
 
2013-021, Rev. 0A, Chapter 19, Beginning through 19-108 (Jun. 2015) (ADAMS Accession Nos. ML15211A223 and ML15211A224). NRC-007J Joseph Donoghue NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-
 
2013-021, Rev. 0A, Chapter 19, 19-109 through End (Jun. 2015) (ADAMS Accession Nos.
ML15211A225 and ML15211A226). NRC-008 MaryJane Ross-Lee Safety Evaluat ion Report Related to the Northwest Medical Isotopes, LLC Construction Permit Application for a Production Facility (Nov. 2017) (ADAMS Accession No. ML18016A021) (as revised Jan. 2018). NRC-009 Joseph Donoghue NUREG-2209, Final Environmental Impact Statement for the Construction Permit for Northwest Medical Isotopes Radioisotope Production Facility (May 2017)  
(ADAMS Accession No. ML17130A862). NRC-010 MaryJane Ross-Lee and Joseph Donoghue Staff Presentation Slides - Overview (Jan. 16, 2018). (ADAMS Accession No. ML18016BA074) NRC-011 MaryJane Ross-Lee Staff Presentation Slides - Safety Panel 1 (Jan. 16, 2018). NRC-012 MaryJane Ross-Lee Staff Presentation Slides - Safety Panel 2 (Jan. 16, 2018). NRC-013 Joseph Donoghue Staff Presentation Slides - Environmental Panel (Jan.
16, 2018). NRC-014 MaryJane Ross-Lee, Joseph Donoghue and Brian Smith NRC Staff Responses to Commission Post-Hearing Questions (Feb. 6, 2018)
 
UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION In the Matter of )  
  )
  )
NORTHWEST MEDICAL ISOTOPES, LLC ) Docket No. 50-609-CP  
NORTHWEST MEDICAL ISOTOPES, LLC ) Docket No. 50-609-CP  
  ) (Medical Radioisotope Production Facility) )  )  
  ) (Medical Radioisotope Production Facility) )  )  


CERTIFICATE OF SERVICE Pursuant to 10 C.F.R. § 2.305, I hereby certify that copies of the foregoing "NRC STAFF REVISED EXHIBIT LIST," dated February 6, 2018, have been served upon the Electronic Information Exchange, the NRC's E-Filing System, in the above-captioned proceeding, this 6th day of February, 2018.  
CERTIFICATE OF SERVICE Pursuant to 10 C.F.R. § 2.305, I hereby certify that copies of the foregoing "NRC STAFF  
  /Signed (electronically) by/      Mitzi A. Young      Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel Mail Stop O14-A44 Washington, DC  20555 Telephone:  (301) 287-9178 E-mail: Mitzi.Young@nrc.gov Dated at Rockville, Maryland this 6th day of February, 2018}}
 
REVISED EXHIBIT LIST," dated February 6, 2018, have been served upon the Electronic Information Exchange, the NRC's E-Filing System
, in the above-captioned proceeding, this 6th day of February, 2018.  
 
  /Signed (electronically) by/      Mitzi A. Young      Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel  
 
Mail Stop O14-A44 Washington, DC  20555 Telephone:  (301) 287-9178 E-mail:
Mitzi.Young@nrc.gov Dated at Rockville, Maryland  
 
this 6th day of February, 2018}}

Revision as of 03:52, 29 June 2018

NRC Staff Revised Exhibit List
ML18037B126
Person / Time
Site: Northwest Medical Isotopes
Issue date: 02/06/2018
From: Wachutka J L, Young M A
NRC/OGC
To:
NRC/OCM
SECY RAS
References
Construction Permit Mndtry Hrg, M 50-609-CP, RAS 54217
Download: ML18037B126 (5)
v • d • e


Text

February 6, 2018 UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION In the Matter of )

) NORTHWEST MEDICAL ISOTOPES, LLC ) Docket No. 50-609-CP )

(Medical Radioisotope Production Facility) )

)

NRC STAFF REVISED EXHIBIT LIST The U.S. Nuclear Regulatory Commission (NRC) staff (Staff) hereby files its revised exhibit list for the mandatory hearing on the construction permit application of Northwest Medical Isotopes, LLC (NWMI) to reflect the inclusion of Exhibit NRC-014, "NRC Staff Responses to Commission Post-Hearing Questions," which was filed today. As noted in that exhibit, NWMI does not object to the admission of NRC-014.

Respectfully submitted,

/Signed (electronically) by/ Mitzi A. Young Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel Mail Stop O14-A44 Washington, DC 20555 Telephone: (301) 287-9178

E-mail: Mitzi.Young@nrc.gov Executed in accord with 10 CFR 2.304(d)

Jeremy L. Wachutka Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel

Mail Stop O14-A44 Washington, DC 20555 Telephone: (301) 287-9188

E-mail : Jeremy.Wachutka@nrc.gov Dated at Rockville, Maryland this 6th day of February, 2018

Staff Exhibits for NWMI Mandatory Hearing (Revised February 6, 2018)

Exhibit Number Sponsoring Witness(es)

Document Description/Title NRC-001 MaryJane Ross-Lee and Joseph Donoghue SECY-17-0116, Staff Statement in Support of the Uncontested Hearing for Issuance of a Construction Permit for the Northwest Medical Isotopes, LLC Production Facility (Nov. 16, 2017) (ADAMS Accession No. ML17313A037). NRC-002 MaryJane Ross-Lee Draft Construc tion Permit for Northwest Medical Isotopes, LLC (Nov. 17, 2017) (ADAMS Accession No. ML17313A100) (revised Jan. 16, 2018). NRC-003 Joseph Donoghue Draft Summary Record of Decision, Construction Permit Application for the Northwest Medical Isotopes, LLC Radioisotope Production Facility (Nov.

17, 2017) (ADAMS Accession No. ML17313A338)

(revised Jan. 16, 2018). NRC-004 MaryJane Ross-Lee and Joseph Donoghue NRC Staff Revised Responses to Commission Pre-Hearing Questions (Jan. 16, 2018) (ADAMS Accession No. ML18016A554). NRC-005 MaryJane Ross-Lee and Joseph Donoghue NON-PUBLIC - NRC Staff Responses to Non-Public Pre-Hearing Questions and Non-Public Response to Question 36 (Jan. 2, 2018)

(ADAMS Accession No. ML18002A546). NRC-006A MaryJane Ross-Lee Northwest M edical Isotopes, LLC, Construction Permit Application - Cover Letter and General and Financial Information (Feb. 5, 2015) (ADAMS Accession Nos. ML15086A262 and ML15086A263 (in

part)). NRC-006B MaryJane Ross-Lee Northwest M edical Isotopes, LLC, Construction Permit Application - Preliminary Safety Analysis Report (PSAR), NWMI-2013-021, Rev. 3, Chapters 1 through 2 (Sep. 2017) (ADAMS Accession Nos.

ML17257A022 and ML17257A023). NRC-006C MaryJane Ross-Lee Northwest M edical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3,

Chapter 3 (Sep. 2017) (ADAMS Accession No.

ML17257A024). NRC-006D MaryJane Ross-Lee Northwest M edical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 4 (Sep. 2017) (ADAMS Accession No. ML17257A025). NRC-006E MaryJane Ross-Lee Northwest M edical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3,

Chapters 5 through 10 (Sep. 2017) (ADAMS Accession Nos. ML17257A026, ML17257A027, ML17257A028, ML17257A029, ML17257A030, and ML17257A031, respectively).

NRC-006F MaryJane Ross-Lee Northwest M edical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 11 through 12 (Sep. 2017) (ADAMS Accession Nos. ML17257A032 and ML17257A033). NRC-006G MaryJane Ross-Lee Northwest M edical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 13 through 18 (Sep. 2017) (ADAMS Accession Nos. ML17257A034, ML17257A035, ML17257A036, ML17257A037, ML17257A038, and ML17257A040, respectively). NRC-006H Joseph Donoghue Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev.

OA, Chapter 19, Beginning through 19-130 (Jun.

2015) (ADAMS Accession Nos. ML15210A123 and ML15210A131). NRC-006I Joseph Donoghue Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. OA, Chapter 19,19-131 through End (Jun. 2015)

(ADAMS Accession Nos. ML15210A128 and ML15210A129). NRC-007A MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - General and Financial Information (Feb. 5, 2015) (ADAMS Accession No. ML15086A272 (in part)). NRC-007B MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 1 through 2 (Sep. 2017)

(ADAMS Accession Nos. ML17257A044 and ML17257A045). NRC-007C MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-

2013-021, Rev. 3, Chapter 3 (Sep. 2017) (ADAMS Accession No. ML17257A046). NRC-007D MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapter 4 (Sep. 2017) (ADAMS Accession No. ML17257A047). NRC-007E MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-

2013-021, Rev. 3, Chapters 5 through 8 (Sep. 2017)

(ADAMS Accession Nos. ML17257A048, ML17257A049, ML17257A050, and ML17257A051, respectively). NRC-007F MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-

2013-021, Rev. 3, Chapters 9 through 11 (Sep.

2017) (ADAMS Accession Nos. ML17257A052, ML17257A053, and ML17257A054, respectively).

NRC-007G MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-

2013-021, Rev. 3, Chapters 12 through 13 (Sep.

2017) (ADAMS Accession Nos. ML17257A055 and ML17257A056).

NRC-007H MaryJane Ross-Lee NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-2013-021, Rev. 3, Chapters 14 through 18 (Sep. 2017) (ADAMS Accession Nos. ML17257A057, ML17257A058, ML17257A059, ML17257A060, and ML17257A061, respectively). NRC-007I Joseph Donoghue NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-

2013-021, Rev. 0A, Chapter 19, Beginning through 19-108 (Jun. 2015) (ADAMS Accession Nos. ML15211A223 and ML15211A224). NRC-007J Joseph Donoghue NON-PUBLIC - Northwest Medical Isotopes, LLC, Construction Permit Application - PSAR, NWMI-

2013-021, Rev. 0A, Chapter 19,19-109 through End (Jun. 2015) (ADAMS Accession Nos.

ML15211A225 and ML15211A226). NRC-008 MaryJane Ross-Lee Safety Evaluat ion Report Related to the Northwest Medical Isotopes, LLC Construction Permit Application for a Production Facility (Nov. 2017) (ADAMS Accession No. ML18016A021) (as revised Jan. 2018). NRC-009 Joseph Donoghue NUREG-2209, Final Environmental Impact Statement for the Construction Permit for Northwest Medical Isotopes Radioisotope Production Facility (May 2017)

(ADAMS Accession No. ML17130A862). NRC-010 MaryJane Ross-Lee and Joseph Donoghue Staff Presentation Slides - Overview (Jan. 16, 2018). (ADAMS Accession No. ML18016BA074) NRC-011 MaryJane Ross-Lee Staff Presentation Slides - Safety Panel 1 (Jan. 16, 2018). NRC-012 MaryJane Ross-Lee Staff Presentation Slides - Safety Panel 2 (Jan. 16, 2018). NRC-013 Joseph Donoghue Staff Presentation Slides - Environmental Panel (Jan.

16, 2018). NRC-014 MaryJane Ross-Lee, Joseph Donoghue and Brian Smith NRC Staff Responses to Commission Post-Hearing Questions (Feb. 6, 2018)

UNITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE COMMISSION In the Matter of )

)

NORTHWEST MEDICAL ISOTOPES, LLC ) Docket No. 50-609-CP

) (Medical Radioisotope Production Facility) ) )

CERTIFICATE OF SERVICE Pursuant to 10 C.F.R. § 2.305, I hereby certify that copies of the foregoing "NRC STAFF

REVISED EXHIBIT LIST," dated February 6, 2018, have been served upon the Electronic Information Exchange, the NRC's E-Filing System

, in the above-captioned proceeding, this 6th day of February, 2018.

/Signed (electronically) by/ Mitzi A. Young Counsel for the NRC Staff U.S. Nuclear Regulatory Commission Office of the General Counsel

Mail Stop O14-A44 Washington, DC 20555 Telephone: (301) 287-9178 E-mail:

Mitzi.Young@nrc.gov Dated at Rockville, Maryland

this 6th day of February, 2018

Retrieved from "https://kanterella.com/w/index.php?title=ML18037B126&oldid=731613"